TaqMan Assay for Swedish Chlamydia trachomatis Variant
To the Editor: Chlamydia trachomatis (CT) is the most prevalent bacterial sexually transmitted infection worldwide. Recently, a new variant of CT (swCT) has been reported in Halland County, Sweden. A total of 12 swCT specimens were sequenced and found to have the same deletion, a 377-bp deletion in the cryptic plasmid (1) . Because the deletion was found in the target area of 2 commercial CT nucleic acid amplifi cation tests (Roche, Basel, Switzerland, and Abbott Laboratories, Abbott Park, IL, USA), screening tests have produced false-negative results for patients infected with this new Swedish variant (1) . In specifi c regions of Sweden, the proportion of all detected CT cases attributable to swCT ranges from 13% to 39%; a considerable number of chlamydia infections have escaped detection by commonly used test systems (1) .
Although the fi rst 2 studies to monitor potential spread of the swCT variant outside Sweden (Ireland and the Netherlands) did not detect swCT, a third study (Norway) did identify this variant (2) (3) (4) . Subsequently, the European Surveillance of Sexually Transmitted Infections network and the European Center for Disease Prevention and Control launched an initiative, consisting of a short questionnaire, to learn more about this swCT variant problem outside Sweden (5) .
However, quick monitoring of the spread of the swCT variant has been hampered by lack of a direct test to detect this swCT variant and by lack of a readily available positive control. We therefore constructed a positive control by using a clinical specimen of the swCT variant in which the deletion was present (forward swCT 5′-TCC GGA TAG TGA ATT ATA GAG ACT ATT TAA TC-3′ reverse swCT 5′GGT GTT TGT ACT AGA GGA CTT ACC TCT TC-3′) (2). The specimen was obtained in Sweden (by B.H.) and confi rmed as swCT by the method described by Ripa and Nilsson (6) . The obtained 98-bp amplicon was subsequently cloned in a pGEM-T Easy Vector (Promega Benelux b.v., Leiden, the Netherlands) and transformed in Escherichia coli DH5α. After extraction the plasmid was verifi ed for the correct insert by sequencing and quantifi ed as described (7). This positive control is available for researchers and clinicians free of charge.
Subsequently, we developed a real-time PCR (TaqMan assay) that specifi cally detects the swCt variant by using a probe that spans the 377-bp left and right gap border sequences: probe-swCT 5′-FAM GGA TCC GTT TGT TCT GG MGB -3′. One copy of cloned positive swCT control could be detected in our swCT assay. We selected 10 copies per PCR as positive swCT control for each run. A total of 239 recent samples known to be CT positive and identifi ed with techniques detecting the swCT variant were retrospectively analyzed with our new Cohort 1 consisted of cervical swabs in 2-sucrose-phosphate (2SP) transport medium, stored at -80°C. Cohort 2 consisted of frozen dry swabs that had been shaken for 10 s in 1 mL 2SP transport medium before sample preparation. Cohort 3 consisted of positive cultured samples. DNA extraction used 200 μL 2SP and was performed with the NucliSens easyMAG (bioMérieux, Boxtel, the Netherlands); the DNA was eluted in 110 μL 2SP (7). Presence of CT DNA was reconfi rmed for all samples with our in-house PCR. Sensitivity of this assay was determined by using a previously described serial dilution of lymphogranuloma venereum (LGV) strain L2 and was assessed at 0.01 inclusionforming units (9) . Amplifi cation and detection were performed with an ABI Prism 7000 sequence detection system (Applied Biosystems, Foster City, CA, USA) by standard PCR conditions of the manufacturer, with 45 cycles. The Swedish variant was found in none of the 3 cohorts tested. Sensitivity and specifi city were confi rmed by using 12 swCT variant samples from Sweden, which were all positive according to our swCT TaqMan assay.
Our new swCT TaqMan assay, combined with the positive control (which can be obtained by contacting S.M.), will be a helpful tool for determining whether this Swedish CT variant is present outside Sweden, other than in the 2 case-patients identifi ed in Norway. We did not fi nd any evidence of the swCT variant in the Netherlands or St. Petersburg, Russia, each of which is near Scandinavia (Table) . Recently, the C. trachomatis LGV strain was discovered in the Netherlands in a population of men who have sex with Highly Pathogenic Porcine Reproductive and Respiratory Syndrome, China
To the Editor: Since April 2006, a highly pathogenic disease caused by unknown agents and characterized by high fever and a high proportion of deaths in pigs of all ages, emerged in some swine farms in Jiangxi Province, People's Republic of China. The morbidity rate was 50%-100% and mortality rate was 20%-100%. In the next several months, the disease spread rapidly to most provinces of China. In almost all affected swine herds, the following clinical signs were observed: high and continuous fever, anorexia, red discolorations in the bodies, and blue ears; in the late phase of the disease, diarrhea and other clinical signs might be seen due to the secondary infections. Clinical samples (from lungs, kidneys, liver, and lymph nodes) were collected from animals in different provinces and sent for laboratory diagnosis. DNA and RNA were extracted from the tissue homogenate and PCR or reverse transcription-PCR (RT-PCR) was conducted to detect porcine reproductive and respiratory syndrome virus (PRRSV), classic swine fever virus, porcine circovirus, and pseudorabies virus, respectively (1) . In clinical samples, only PRRSV was found to be the dominant virus (48 of 50 samples were PRRSV posi- 
